4//SEC Filing
Sweeny Nicole 4
Accession 0001104659-22-003164
CIK 0001689548other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 4:09 PM ET
Size
7.6 KB
Accession
0001104659-22-003164
Insider Transaction Report
Form 4
Sweeny Nicole
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-01-07+24,000→ 40,800 total - Award
Stock Option (Right to Buy)
2022-01-07+84,000→ 84,000 totalExercise: $18.11Exp: 2032-01-07→ Common Stock (84,000 underlying)
Footnotes (2)
- [F1]Ms. Sweeny was awarded 24,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.
Documents
Issuer
Praxis Precision Medicines, Inc.
CIK 0001689548
Entity typeother
Related Parties
1- filerCIK 0001827505
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 4:09 PM ET
- Size
- 7.6 KB